Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three months and six months ended September 30, 2014.
Quarter ended September 30, 2014 Highlights - compared to September 30, 2013
•Net sales of $250.8 million, increased $45.5 million, or 22.2%, with a decrease in volumes
Help employers find you! Check out all the jobs and post your resume.
